Holdings
ProShares Ultra Health Care
As of May 31, 2026, ProShares Ultra Health Care reported 59 positions worth US$56.2M. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 8,263 | US$9.13M | −802 | May 31, 2026 |
| Johnson & Johnson | 25,129 | US$5.66M | −2,378 | May 31, 2026 |
| Abbvie Inc. | 18,435 | US$4.01M | −1,738 | May 31, 2026 |
| Unitedhealth Group Incorporated | 9,446 | US$3.59M | −895 | May 31, 2026 |
| Merck & Company, Inc. | 25,881 | US$3.07M | −2,449 | May 31, 2026 |
| Thermo Fisher Scientific Inc | 3,918 | US$1.93M | −370 | May 31, 2026 |
| Amgen Inc. | 5,616 | US$1.89M | −531 | May 31, 2026 |
| Gilead Sciences, Inc. | 12,937 | US$1.74M | −1,224 | May 31, 2026 |
| Intuitive Surgical, Inc. | 3,704 | US$1.57M | −344 | May 31, 2026 |
| Pfizer, Inc. | 59,288 | US$1.55M | −5,610 | May 31, 2026 |